ipmn

Showing 1 - 9 of 9

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pancreatic Cyst, Pancreas Cyst, Serous Cystadenoma Trial in France (Molecular biology analysis of pancreatic intra-cyst fluid)

Active, not recruiting
  • Pancreatic Cyst
  • +4 more
  • Molecular biology analysis of pancreatic intra-cyst fluid
  • Charenton-le-Pont, France
  • +10 more
Apr 13, 2022

Genomic Resources for Enhancing Available Therapies Study

Recruiting
  • Chronic Pancreatitis
  • +26 more
  • venipuncture
  • +2 more
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Medical Center
Mar 9, 2022

IPMN, IPMN, Pancreatic Trial in United States (Sulindac 400 MG, Placebo)

Recruiting
  • IPMN
  • IPMN, Pancreatic
  • Sulindac 400 MG
  • Placebo
  • Baltimore, Maryland
  • +3 more
Feb 16, 2022

IPMN, Pancreatic, IPMN Trial in Fitzroy

Recruiting
  • IPMN, Pancreatic
  • IPMN
    • Fitzroy, Victoria, Australia
      St Vincent's Hospital Melbourne
    Nov 2, 2021

    Pancreatic Cancer and Oral Microbiome

    Recruiting
    • Oral Microbiome
    • +3 more
    • Dental plaque sampling
    • qPCR
    • Verona, Italy
    • +1 more
    Aug 5, 2021

    Pancreatic Cancer, Pancreatitis, IPMN Trial (PET/CT results with TOF/without TOF)

    Completed
    • Pancreatic Cancer
    • +2 more
    • PET/CT results with TOF/without TOF
    • (no location specified)
    May 14, 2020

    Pancreatic Cyst, IPMN, Mucinous Cyst Trial in Herlev (EUS-guided microbiopsy, Next Generation Sequencing)

    Completed
    • Pancreatic Cyst
    • +3 more
    • EUS-guided microbiopsy
    • Next Generation Sequencing
    • Herlev, Danmark, Denmark
      Gastro Unit, Division of Endoscopy
    Dec 6, 2019

    IPMN, Quality of Life Trial (IPMN follow up)

    Unknown status
    • IPMN
    • Quality of Life
    • IPMN follow up
    • (no location specified)
    Apr 26, 2017

    Intraductal Papillary Mucinous Neoplasm With Malignant Change

    Terminated
    • IPMN
      • Seoul, Korea, Republic of
        Asan Medical Center
      Jul 20, 2016